Form 4 for CVS CVS Health
Accepted 2026-04-02 16:52:06 ET · period of report 2026-03-31 · accession 0000064803-26-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 16:52 | 2026-03-31 | CVS | Compton-Phillips Amy | EVP, Chief Medical Off | A - Grant | $71.82 | +5,569 | 58.7K | +10% | +$400.0K |
| D | 2026-04-02 16:52 | 2026-03-31 | CVS | Compton-Phillips Amy | EVP, Chief Medical Off | A - Grant | $71.82 | +35.9K | 35.9K | New | +$2.58M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2026-03-31 | A | A | 5,569 | $71.82 | 58,660 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Derivative | Stock Option | 2026-03-31 | A | A | 35,928 | $71.82 | 35,928 | D | $71.82 · 2027-03-31 to 2036-03-31 | 35,928 Common Stock | (F2) Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |